[Federal Register Volume 79, Number 11 (Thursday, January 16, 2014)]
[Pages 2854-2855]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-00715]



Centers for Disease Control and Prevention

[Docket Number CDC-2014-0002; NIOSH 248-A]

World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC or Advisory Committee), National Institute for 
Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
    Time and Date: 9:30 a.m.-5:00 p.m., February 14, 2014 (All times 
are Eastern Standard Time)
    Place: This meeting will be available via telephone and Web 
Conference. Audio will be available by telephone and visuals will be 
available by Web Conference. The USA toll-free, dial-in number is 1 
(888) 381-5771. To be connected to the meeting, you will need to 
provide the following participant code to the operator: 8501294. To 
obtain further instructions on how to access the meeting online through 
Web Conference, see the instructions at the Committee's meeting Web 
site: http://www.cdc.gov/wtc/stac_meeting.html.
    Public Comment Time and Date: 11:30 a.m.-12:15 p.m., February 14, 
    Please note that the public comment period ends at the time 
indicated above or following the last call for comments, whichever is 
earlier. Members of the public who want to comment must sign up by 
providing their name by mail, email, or telephone, at the addresses 
provided below, by February 10, 2014. Each commenter will be provided 
up to five minutes for comment. A limited number of time slots are 
available and will be assigned on a first come-first served basis. 
Written comments will also be accepted from those unable to attend the 
public session.
    Status: Open to the public, limited only by the number of telephone 
lines. The conference line will accommodate up to 100 callers; 
therefore it is suggested that those interested in calling in to listen 
to the committee meeting share a line when possible.
    Background: The Advisory Committee was established by Public Law 
111-347 (The James Zadroga 9/11 Health and Compensation Act of 2010, 
Title XXXIII of the Public Health Service Act), enacted on January 2, 
2011 and codified at 42 U.S.C. sec. 300mm-300mm-61.
    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
World Trade Center (WTC) Program Administrator regarding additional WTC 
Health Program eligibility criteria and potential additions to the list 
of covered WTC-related health conditions. Title XXXIII of the Public 
Health Service Act established within the Department of Health and 
Human Services (HHS), the World Trade Center (WTC) Health Program, to 
be administered by the WTC Program Administrator. The WTC Health 
Program provides: (1) Medical monitoring and treatment benefits to 
eligible emergency responders and recovery and cleanup workers 
(including those who are Federal employees) who responded to the 
September 11, 2001, terrorist attacks, and (2) initial health 
evaluation, monitoring, and treatment benefits to residents and other 
building occupants and area workers in New York City, who were directly 
impacted and adversely affected by such attacks (``survivors''). 
Certain specific activities of the WTC Program Administrator are 
reserved to the Secretary, HHS, to delegate at her discretion; other 
WTC Program Administrator duties not explicitly reserved to the 
Secretary, HHS, are assigned to the Director, NIOSH. The administration 
of the Advisory Committee established under Section 300mm-1(a) is left 
to the Director of NIOSH in his role as WTC Program Administrator. CDC 
and NIOSH provide funding, staffing, and administrative support 
services for the Advisory Committee. The charter was reissued on May 9, 
2013, and will expire on May 9, 2015.
    Matters To Be Discussed: The agenda for the Advisory Committee 
meeting includes a brief update on the policies and regulations 
developed by the WTC Health Program and development of recommendations 
for research.
    The agenda is subject to change as priorities dictate.
    To view the notice, visit http://www.regulations.gov and enter CDC-

[[Page 2855]]

2014-0002 in the search field and click ``Search.''
    Public Comment Sign-up and Submissions to the Docket: To sign up to 
provide public comments or to submit comments to the docket, send 
information to the NIOSH Docket Office by one of the following means:
    Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS-C-34, 
4676 Columbia Parkway, Cincinnati, Ohio 45226.
    Email: [email protected].
    Telephone: (513) 533-8611.
    In the event an individual cannot attend, written comments may be 
submitted. The comments should be limited to two pages and submitted 
through http://www.regulations.gov by February 10, 2014. Efforts will 
be made to provide the two-page written comments received by the 
deadline below to the committee members before the meeting. Comments in 
excess of two pages will be made publicly available at http://www.regulations.gov. To view background information and previous 
submissions go to NIOSH docket http://www.cdc.gov/niosh/docket/archive/docket248.html.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to http://www.regulations.gov within 60 days after the meeting. If a person 
making a comment gives his or her name, no attempt will be made to 
redact that name. NIOSH will take reasonable steps to ensure that 
individuals making public comments are aware of the fact that their 
comments (including their name, if provided) will appear in a 
transcript of the meeting posted on a public Web site. Such reasonable 
steps include a statement read at the start of the meeting stating that 
transcripts will be posted and names of speakers will not be redacted. 
If individuals in making a statement reveal personal information (e.g., 
medical information) about themselves, that information will not 
usually be redacted. The CDC Freedom of Information Act coordinator 
will, however, review such revelations in accordance with the Freedom 
of Information Act and, if deemed appropriate, will redact such 
information. Disclosures of information concerning third party medical 
information will be redacted.
    Contact Person For More Information: Paul J. Middendorf, Ph.D., 
Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., Mail 
Stop E-20, Atlanta, Georgia 30345, telephone 1 (888) 982-4748; email: 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2014-00715 Filed 1-15-14; 8:45 am]